The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $16.24

Today's change-0.29 -1.75%
Updated September 4 4:03 PM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $16.24

Today's change-0.29 -1.75%
Updated September 4 4:03 PM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp crosses below 200-day moving average

Boston Scientific Corp closed sharply lower Friday, dropping (U.S.)$0.29 or 1.75% to (U.S.)$16.24 and crossing below its 200-day moving average. Shares have lost 4.86% over the last five days, but have gained 22.57% over the last year to date. This security has outperformed the S&P 500 by 36.51% during the last year.

Key company metrics

  • Open(U.S.) $16.30
  • Previous close(U.S.) $16.53
  • High(U.S.) $16.43
  • Low(U.S.) $16.00
  • Bid / Ask-- / --
  • YTD % change+22.57%
  • Volume5,427,913
  • Average volume (10-day)8,981,841
  • Average volume (1-month)8,146,818
  • Average volume (3-month)8,684,526
  • 52-week range(U.S.) $11.10 to (U.S.) $18.62
  • Beta1.02
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.89×
  • Forward PEG1.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.12
Updated September 4 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.87%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue1,8431,7681,8871,846
Total other revenue--------
Total revenue1,8431,7681,8871,846
Gross profit1,3111,2561,3371,305
Total cost of revenue532512550541
Total operating expense1,6241,7442,3791,782
Selling / general / administrative696660746735
Research & development220192208212
Depreciation / amortization116113111109
Interest expense (income), net operating--------
Unusual expense (income)42250739164
Other operating expenses, total18172521
Operating income21924-49264
Interest income (expense), net non-operating-106-60-55-54
Gain (loss) on sale of assets--------
Other--------
Income before tax105-51-5543
Income after tax102-1-29943
Income tax, total3-50-255-40
Net income102-1-29943
Total adjustments to net income--------
Net income before extra. items102-1-29943
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items102-1-29943
Inc. avail. to common incl. extra. items102-1-29943
Diluted net income102-1-29943
Dilution adjustment--00--
Diluted weighted average shares1,3621,3341,3271,348
Diluted EPS excluding extraordinary itemsvalue per share0.070.00-0.230.03
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.100.120.140.11